Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Predictive Technology Group, Inc. (PRED) Starts Presentation at SeeThruEquity Conference

Predictive Technology Group (OTC: PRED), through wholly owned subsidiaries, is engaged in the treatment of debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. The company develops and acquires proprietary technologies that open windows into the origin of human illness and the role that genes and proteins play in the onset and progression of disease. PRED’s subsidiaries use gene-based information in the development of new diagnostics that assess risk of illness and therapeutic products designed to prevent and treat diseases effectively. For more information, visit the company’s website at

The 5th Annual SeeThruEquity conference, held in New York City, will connect more than 50 presenting companies with microcap-focused investors, sponsors, and industry professionals in attendance. The conference will feature 30-minute presentations by presenting companies, as well as one-on-one meetings with investors. In addition to the large number of companies confirmed to present, SeeThruEquity is hosting a panel composed of industry leaders. For more information on SeeThruEquity, visit
This entry was posted in SeeThruEquity Conference. Bookmark the permalink.

Comments are closed.